Gilead Sciences

NASDAQ: GILD
$74.99
+$0.32 (+0.4%)
Closing price April 8, 2020
Tuesday's top analyst upgrades and downgrades included BHP, Electronic Arts, Gilead Sciences, Immunomedics, KeyCorp, Peloton Interactive, Shopify, Sunnova Energy, Take-Two Interactive and Walt Disney.
Jon C. Ogg
These five top companies have large troves of cash and very little debt. Their stocks make sense for long-term growth investors who have an eye on recovery down the road.
Lee Jackson
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
Paul Ausick
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health and Human Services okayed two drugs for use in the fight against COVID-19.
Paul Ausick
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
Wednesday's top analyst calls included Apple, CenturyLink, Charles Schwab, Coca-Cola, Dow, Facebook, Gilead Sciences, Intel, Medtronic, Square, TJX and Under Armour.
Jon C. Ogg
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Chris Lange
24/7 Wall St. has tracked multiple S&P 500 and other large-cap stocks that actually closed up for the past week and that are also still higher year to date.
Jon C. Ogg
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
Chris Lange
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Thursday’s big drop because they have some aspect of their business that might be immune to daily scares or...
Chris Lange
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
Chris Lange
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange